Dow Up 0.11% Nasdaq Up 0.50%

Sunesis Pharmaceuticals, Inc. (SNSS)

-NasdaqCM
7.49 Down 0.29(3.73%) Aug 29, 4:00PM EDT
|After Hours : 7.56 Up 0.07 (0.93%) Aug 29, 5:32PM EDT
Prev Close:7.78
Open:7.45
Bid:7.56 x 300
Ask:7.98 x 1000
1y Target Est:11.33
Beta:2.8
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:7.27 - 7.73
52wk Range:3.84 - 8.46
Volume:1,903,154
Avg Vol (3m):693,317
Market Cap:452.71M
P/E (ttm):N/A
EPS (ttm):-0.70
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SNSSDown 3.73%452.71M
AZNUp 2.38%96.00B
PFEUp 0.03%186.36B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):59.06
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.74
Quarterly EPS Est (Sep-14) :-0.20
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sunesis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback